Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charles C Hong

Showing results (11-20 of 130) with videos related to

Pageof 13
Sort By:
Chemistry & Biology|April 26, 2011
Regenerative chemical biology: current challenges and future potentialAda Ao, Jijun Hao, Charles C Hong
Biochemical Society Transactions|August 17, 2016
Emerging roles of the bone morphogenetic protein pathway in cancer: potential therapeutic target for kinase inhibitionPawina Jiramongkolchai, Philip Owens, Charles C Hong
ACS Chemical Biology|November 17, 2010
Cardiac induction of embryonic stem cells by a small molecule inhibitor of Wnt/β-catenin signalingHanmin Wang, Jijun Hao, Charles C Hong
Circulation Research|September 18, 2008
Role of crosstalk between phosphatidylinositol 3-kinase and extracellular signal-regulated kinase/mitogen-activated protein kinase pathways in artery-vein specificationCharles C Hong, Tsutomu Kume, Randall T Peterson
Cardiovascular Research|April 7, 2025
Mimicked immunity: a strategy for targeted nanodrug deliveryYapei Zhang, Charles C Hong, Bryan Ronain Smith
Bioorganic & Medicinal Chemistry Letters|March 16, 2016
Development of thieno- and benzopyrimidinone inhibitors of the Hedgehog signaling pathway reveals PDE4-dependent and PDE4-independent mechanisms of actionJonathan E Hempel, Adrian G Cadar, Charles C Hong
Current Cardiology Reports|April 19, 2018
Genome Editing and Induced Pluripotent Stem Cell Technologies for Personalized Study of Cardiovascular DiseasesYoung Wook Chun, Matthew D Durbin, Charles C Hong
Plos One|April 18, 2013
Bone morphogenetic protein type I receptor antagonists decrease growth and induce cell death of lung cancer cell linesElaine Langenfeld, Charles C Hong, Gandhi Lanke, et al.
Methods in Molecular Biology (Clifton, N.J.)|March 17, 2015
Preface. Chemical biologyJonathan E Hempel, Charles H Williams, Charles C Hong
The National High School Journal of Science|June 5, 2026
Optimization of Small-Molecule Wnt Pathway Activation with CHIR99021 for Human Induced Pluripotent Stem Cell Differentiation to CardiomyocytesBhavya Tikaria, Aaron H Wasserman, Bana Abolibdeh, et al.
Pageof 13

Showing results (11-20 of 130) with videos related to

Sort By:
Pageof 13
Chemistry & Biology|April 26, 2011
Regenerative chemical biology: current challenges and future potentialAda Ao, Jijun Hao, Charles C Hong
Biochemical Society Transactions|August 17, 2016
Emerging roles of the bone morphogenetic protein pathway in cancer: potential therapeutic target for kinase inhibitionPawina Jiramongkolchai, Philip Owens, Charles C Hong
ACS Chemical Biology|November 17, 2010
Cardiac induction of embryonic stem cells by a small molecule inhibitor of Wnt/β-catenin signalingHanmin Wang, Jijun Hao, Charles C Hong
Circulation Research|September 18, 2008
Role of crosstalk between phosphatidylinositol 3-kinase and extracellular signal-regulated kinase/mitogen-activated protein kinase pathways in artery-vein specificationCharles C Hong, Tsutomu Kume, Randall T Peterson
Cardiovascular Research|April 7, 2025
Mimicked immunity: a strategy for targeted nanodrug deliveryYapei Zhang, Charles C Hong, Bryan Ronain Smith
Bioorganic & Medicinal Chemistry Letters|March 16, 2016
Development of thieno- and benzopyrimidinone inhibitors of the Hedgehog signaling pathway reveals PDE4-dependent and PDE4-independent mechanisms of actionJonathan E Hempel, Adrian G Cadar, Charles C Hong
Current Cardiology Reports|April 19, 2018
Genome Editing and Induced Pluripotent Stem Cell Technologies for Personalized Study of Cardiovascular DiseasesYoung Wook Chun, Matthew D Durbin, Charles C Hong
Plos One|April 18, 2013
Bone morphogenetic protein type I receptor antagonists decrease growth and induce cell death of lung cancer cell linesElaine Langenfeld, Charles C Hong, Gandhi Lanke, et al.
Methods in Molecular Biology (Clifton, N.J.)|March 17, 2015
Preface. Chemical biologyJonathan E Hempel, Charles H Williams, Charles C Hong
The National High School Journal of Science|June 5, 2026
Optimization of Small-Molecule Wnt Pathway Activation with CHIR99021 for Human Induced Pluripotent Stem Cell Differentiation to CardiomyocytesBhavya Tikaria, Aaron H Wasserman, Bana Abolibdeh, et al.
Pageof 13